<article title='Central_pontine_myelinolysis'><paragraph><template><target>Infobox disease</target><arg name="Name"><space/>Central pontine myelinolysis
</arg><arg name="Image"><space/>Illu pituitary pineal glands.jpg
</arg><arg name="Caption"><space/>Pons labeled at bottom left
</arg><arg name="DiseasesDB"><space/>2198
</arg><arg name="ICD10"><space/>{{ICD10|G|37|2|g|35}}
</arg><arg name="ICD9">
</arg><arg name="ICDO">
</arg><arg name="OMIM">
</arg><arg name="MedlinePlus"><space/>000775
</arg><arg name="eMedicineSubj"><space/>neuro
</arg><arg name="eMedicineTopic"><space/>50
</arg><arg name="MeshID"><space/>D017590
</arg></template><link><target>File:CPM3.jpg</target><part>thumb</part><part>right</part><part>200px</part><part>Central pontine myelinolysis, MRI FLAIR</part></link><link><target>File:MRI Central Pontine Myelinolysis fat sat T2.jpg</target><part>thumb</part><part>right</part><part>200px</part><part>Axial fat-saturated T2-weighted image showing hyperintensity in the pons with sparing of the peripheral fibers, the patient was an alcoholic admitted with a serum Na of 101 treated with hypertonic saline, he was left with quadreparesis, dysarthria, and altered mental status</part></link><bold>Central pontine myelinolysis</bold><space/>(<bold>CPM</bold>), also known as<space/><bold>Osmotic demyelination syndrome</bold><space/>or<space/><bold>Central pontine demyelination</bold>, is a neurological disease caused by severe damage of the<space/><link><target>myelin sheath</target></link><space/>of<space/><link><target>neuron</target><part>nerve cells</part></link><space/>in the<space/><link><target>brainstem</target></link>, more precisely in the area termed the<space/><italics><link><target>pons</target></link></italics>, predominately of<space/><link><target>Iatrogenesis</target><part>iatrogenic</part></link><space/><link><target>etiology</target></link>. It is characterized by acute paralysis,<space/><link><target>dysphagia</target></link><space/>(difficulty swallowing), and<space/><link><target>dysarthria</target></link><space/>(difficulty speaking), and other neurological symptoms.</paragraph><paragraph>It can also occur outside the pons.<extension extension_name='ref' name="pmid3322623"><template><target>cite journal</target><arg name="author">Gocht A, Colmant HJ<space/></arg><arg name="title">Central pontine and extrapontine myelinolysis: a report of 58 cases<space/></arg><arg name="journal">Clin. Neuropathol.<space/></arg><arg name="volume">6<space/></arg><arg name="issue">6<space/></arg><arg name="pages">262–70<space/></arg><arg name="year">1987<space/></arg><arg name="pmid">3322623<space/></arg><arg name="doi"><space/></arg><arg name="url"></arg></template></extension><space/>The term &quot;osmotic demyelination syndrome&quot; is similar to &quot;central pontine myelinolysis&quot;, but also includes areas outside the pons.<extension extension_name='ref' name="pmid11803185"><template><target>cite journal</target><arg name="author">Lampl C, Yazdi K<space/></arg><arg name="title">Central pontine myelinolysis<space/></arg><arg name="journal">Eur. Neurol.<space/></arg><arg name="volume">47<space/></arg><arg name="issue">1<space/></arg><arg name="pages">3–10<space/></arg><arg name="year">2002<space/></arg><arg name="pmid">11803185<space/></arg><arg name="doi"><space/>10.1159/000047939</arg><arg name="url">http://content.karger.com/produktedb/produkte.asp?typ</arg><arg name="archiveurl"><space/>http://www.webcitation.org/5uKw9BaG1<space/></arg><arg name="archivedate"><space/>2010-11-18</arg><arg name="deadurl">no</arg></template></extension></paragraph><paragraph>Central pontine myelinolysis presents most commonly as a complication of treatment of patients with profound, life-threatening<space/><link><target>hyponatremia</target></link><space/>(low<space/><link><target>sodium</target></link>). It occurs as a consequence of a rapid rise in<space/><link><target>serum (blood)</target><part>serum</part></link><space/><link><target>tonicity</target></link><space/>following treatment in individuals with chronic, severe hyponatremia who have made intracellular adaptations to the prevailing hypotonicity.<extension extension_name='ref' name="babar"><template><target>cite journal</target><arg name="pmid"><space/>24259701</arg><arg name="quote"><space/></arg><arg name="date">October 2013<space/></arg><arg name="last1">Babar<space/></arg><arg name="first1">S.</arg><arg name="title">SIADH Associated With Ciprofloxacin.</arg><arg name="url">http://aop.sagepub.com/content/47/10/1359.full.pdf</arg><arg name="volume">47<space/></arg><arg name="issue">10<space/></arg><arg name="pages">1359–1363<space/></arg><arg name="issn">1060-0280<space/></arg><arg name="journal">Annals of Pharmacotherapy</arg><arg name="doi">10.1177/1060028013502457</arg><arg name="accessdate">November 18, 2013<space/></arg><arg name="publisher">Sage Publishing<space/></arg><arg name="pmc"></arg></template></extension><space/>Hyponatremia should be corrected at a rate of no more than 12-20&amp;nbsp;mmol/L of sodium per day to prevent central pontine myelinolysis.<extension extension_name='ref' name="babar"></extension></paragraph><paragraph>Although less common, it may also present in patients with a history of chronic<space/><link><target>alcoholism</target></link><space/>or other conditions related to decreased liver function. In these cases, the condition is often unrelated to correction of sodium or<space/><link><target>electrolyte</target></link><space/>imbalance.</paragraph><heading level='2'>Pathophysiology</heading><paragraph>The currently accepted theory states that the brain cells adjust their<space/><link><target>osmolarity</target><part>osmolarities</part></link><space/>by changing levels of certain osmolytes like<space/><link><target>inositol</target></link>,<space/><link><target>betaine</target></link>, and<space/><link><target>glutamine</target></link>. In hyponatremia the levels of these osmolytes fall, causing the cells to absorb free-water. The reverse is true for hypernatremia, in which cells will shrink to dilute the hypernatremic fluid. So rapid correction of sodium in hyponatremia would cause the extracellular fluid to be relatively hypertonic. Free water would then move out of the cells to decrease this relative hypertonicity. This leads to a central pontine myelinolysis, manifesting as the paralysis. The brain appears to shrink.</paragraph><paragraph>The demyelination of the<space/><link><target>axon</target><trail>s</trail></link><space/>(nerve fibers in the brain) damages them.<extension extension_name='ref' name="pmid12566274"><template><target>cite journal</target><arg name="author">Medana IM, Esiri MM
</arg><arg name="title">Axonal damage: a key predictor of outcome in human CNS diseases
</arg><arg name="journal">Brain
</arg><arg name="volume">126
</arg><arg name="issue">Pt 3
</arg><arg name="pages">515–30
</arg><arg name="date">March 2003
</arg><arg name="pmid">12566274
</arg><arg name="doi">10.1093/brain/awg061
</arg><arg name="url">http://brain.oxfordjournals.org/cgi/pmidlookup?view</arg></template></extension></paragraph><paragraph>In the context of<space/><link><target>Chronic (medicine)</target><part>chronic</part></link><space/>low plasma sodium, the brain's cells (<link><target>neurons</target></link><space/>and<space/><link><target>glia</target></link>) adapt by taking in a small amount of water; the net effect is to move water out of the<space/><link><target>interstitium</target></link><space/>and<space/><link><target>Diffusion equilibrium</target><part>equilibrate</part></link><space/>(or nearly so) the intracellular and extracellular tonicities. The chronic hyponatremia is thus compensated.</paragraph><paragraph>With correction of the hyponatremia with<space/><link><target>intravenous fluids</target></link>, the intra- and extra-cellular tonicities are again changed, this time in the opposite direction. With the use of intravenous hypertonic saline, the correction can be too quick, not allowing enough time for the brain's cells to adjust to the new tonicity. With a rise in extracellular tonicity, the cells compensate by losing a small amount of water. This loss will continue until the intra- and extra-cellular tonicities are equal. If hypertonic therapy continues or is too rapid, the extracellular tonicity will continue to drive water out of the brain's cells, leading to cellular dysfunction and the condition of central pontine myelinolysis.</paragraph><paragraph>Rapid correction of hypernatremia causes water to move into cells, leading to multiple cerebral hemorrhages, which is as catastrophic as osmotic<space/><link><target>demyelination</target></link>.</paragraph><heading level='2'>Causes</heading><paragraph><link><target>File:Pontine myelinolysis.jpg</target><part>thumb</part><part>right</part><part>Loss of myelinated fibers at the basis pontis in the brainstem (Luxol-Fast blue stain)</part></link>The most common cause is the too rapid correction of low blood sodium levels (<link><target>hyponatremia</target></link>).<extension extension_name='ref' name="pmid10544728"><template><target>cite journal</target><arg name="author">Bernsen HJ, Prick MJ<space/></arg><arg name="title">Improvement of central pontine myelinolysis as demonstrated by repeated magnetic resonance imaging in a patient without evidence of hyponatremia<space/></arg><arg name="journal">Acta Neurol Belg<space/></arg><arg name="volume">99<space/></arg><arg name="issue">3<space/></arg><arg name="pages">189–93<space/></arg><arg name="date">September 1999<space/></arg><arg name="pmid">10544728<space/></arg><arg name="doi"><space/></arg><arg name="url"></arg></template></extension></paragraph><paragraph>It has also been known to occur in patients suffering withdrawal symptoms of chronic<space/><link><target>alcoholism</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Yoon B, Shim YS, Chung SW<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="title"><space/>Central Pontine and Extrapontine Myelinolysis After Alcohol Withdrawal<space/></arg><arg name="url"><space/>http://alcalc.oxfordjournals.org/content/43/6/647.full<space/></arg><arg name="journal"><space/>Alcohol<space/></arg><arg name="volume"><space/>43<space/></arg><arg name="issue"><space/>6</arg><arg name="pages"><space/>647–9<space/></arg><arg name="doi">10.1093/alcalc/agn050</arg></template></extension><space/>In these instances, occurrence may be entirely unrelated to hyponatremia or rapid correction of hyponatremia.</paragraph><paragraph>It has been observed following<space/><link><target>hematopoietic stem cell transplantation</target></link>.<extension extension_name='ref' name="pmid18437020"><template><target>cite journal</target><arg name="author">Lim KH, Kim S, Lee YS<space/></arg><arg name="title">Central pontine myelinolysis in a patient with acute lymphoblastic leukemia after hematopoietic stem cell transplantation: a case report<space/></arg><arg name="journal">J. Korean Med. Sci.<space/></arg><arg name="volume">23<space/></arg><arg name="issue">2<space/></arg><arg name="pages">324–7<space/></arg><arg name="date">April 2008<space/></arg><arg name="pmid">18437020<space/></arg><arg name="pmc">2526450<space/></arg><arg name="doi">10.3346/jkms.2008.23.2.324<space/></arg><arg name="url">http://jkms.org/contents/jkms.php?pubyear</arg><arg name="display-authors">etal</arg></template><template><target>dead link</target><arg name="date">May 2010</arg></template></extension></paragraph><paragraph>CPM may also occur in patients affected by</paragraph><list type='bullet'><listitem>severe liver disease</listitem><listitem>liver transplant<extension extension_name='ref' name="pmid8152365"><template><target>cite journal</target><arg name="author">Singh N, Yu VL, Gayowski T<space/></arg><arg name="title">Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management<space/></arg><arg name="journal">Medicine (Baltimore)<space/></arg><arg name="volume">73<space/></arg><arg name="issue">2<space/></arg><arg name="pages">110–8<space/></arg><arg name="date">March 1994<space/></arg><arg name="pmid">8152365<space/></arg><arg name="doi"><space/>10.1097/00005792-199403000-00004</arg><arg name="url"><space/></arg><arg name="accessdate">2014-05-29</arg></template></extension><extension extension_name='ref' name="pmid11934516"><template><target>cite journal</target><arg name="author">Kato T, Hattori H, Nagato M, Kiuchi T, Uemoto S, Nakahata T, Tanaka K<space/></arg><arg name="title">Subclinical central pontine myelinolysis following liver transplantation<space/></arg><arg name="journal">Brain Dev.<space/></arg><arg name="volume">24<space/></arg><arg name="issue">3<space/></arg><arg name="pages">179–82<space/></arg><arg name="date">April 2002<space/></arg><arg name="pmid">11934516<space/></arg><arg name="doi"><space/>10.1016/S0387-7604(02)00013-X</arg><arg name="url">http://linkinghub.elsevier.com/retrieve/pii/S038776040200013X<space/></arg><arg name="accessdate">2014-05-29</arg></template></extension><extension extension_name='ref' name="pmid3047544"><template><target>cite journal</target><arg name="author">Martinez AJ, Estol C, Faris AA<space/></arg><arg name="title">Neurologic complications of liver transplantation<space/></arg><arg name="journal">Neurol Clin<space/></arg><arg name="volume">6<space/></arg><arg name="issue">2<space/></arg><arg name="pages">327–48<space/></arg><arg name="date">May 1988<space/></arg><arg name="pmid">3047544<space/></arg><arg name="doi"><space/></arg><arg name="url"><space/></arg><arg name="accessdate">2014-05-29</arg></template></extension></listitem><listitem>alcoholism</listitem><listitem>severe burns<extension extension_name='ref' name="pmid3399069"><template><target>cite journal</target><arg name="author">McKee AC, Winkelman MD, Banker BQ<space/></arg><arg name="title">Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality<space/></arg><arg name="journal">Neurology<space/></arg><arg name="volume">38<space/></arg><arg name="issue">8<space/></arg><arg name="pages">1211–7<space/></arg><arg name="date">August 1988<space/></arg><arg name="pmid">3399069<space/></arg><arg name="doi"><space/>10.1212/wnl.38.8.1211</arg><arg name="url"><space/></arg><arg name="accessdate">2014-05-29</arg></template></extension><extension extension_name='ref' name="pmid1522803"><template><target>cite journal</target><arg name="author">Winkelman MD, Galloway PG<space/></arg><arg name="title">Central nervous system complications of thermal burns. A postmortem study of 139 patients<space/></arg><arg name="journal">Medicine (Baltimore)<space/></arg><arg name="volume">71<space/></arg><arg name="issue">5<space/></arg><arg name="pages">271–83<space/></arg><arg name="date">September 1992<space/></arg><arg name="pmid">1522803<space/></arg><arg name="doi"><space/>10.1097/00005792-199209000-00002</arg><arg name="url"><space/></arg><arg name="accessdate">2014-05-29</arg></template></extension></listitem><listitem>malnutrition</listitem><listitem>anorexia<extension extension_name='ref' name="pmid12588925"><template><target>cite journal</target><arg name="author">Sugimoto T, Murata T, Omori M, Wada Y<space/></arg><arg name="title">Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa<space/></arg><arg name="journal">J. Neurol. Neurosurg. Psychiatr.<space/></arg><arg name="volume">74<space/></arg><arg name="issue">3<space/></arg><arg name="pages">353–5<space/></arg><arg name="date">March 2003<space/></arg><arg name="pmid">12588925<space/></arg><arg name="pmc">1738317<space/></arg><arg name="doi"><space/>10.1136/jnnp.74.3.353</arg><arg name="url">http://jnnp.bmj.com/cgi/pmidlookup?view</arg><arg name="accessdate">2014-05-29</arg></template></extension><extension extension_name='ref' name="pmid15026526"><template><target>cite journal</target><arg name="author">Keswani SC<space/></arg><arg name="title">Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa<space/></arg><arg name="journal">J. Neurol. Neurosurg. Psychiatr.<space/></arg><arg name="volume">75<space/></arg><arg name="issue">4<space/></arg><arg name="pages">663; author reply 663<space/></arg><arg name="date">April 2004<space/></arg><arg name="pmid">15026526<space/></arg><arg name="pmc">1739009<space/></arg><arg name="doi"><space/></arg><arg name="url">http://jnnp.bmj.com/cgi/pmidlookup?view</arg><arg name="accessdate">2014-05-29</arg></template></extension><extension extension_name='ref' name="pmid22473289"><template><target>cite journal</target><arg name="author">Leroy S, Gout A, Husson B, de Tournemire R, Tardieu M<space/></arg><arg name="title">Centropontine myelinolysis related to refeeding syndrome in an adolescent suffering from anorexia nervosa<space/></arg><arg name="journal">Neuropediatrics<space/></arg><arg name="volume">43<space/></arg><arg name="issue">3<space/></arg><arg name="pages">152–4<space/></arg><arg name="date">June 2012<space/></arg><arg name="pmid">22473289<space/></arg><arg name="doi">10.1055/s-0032-1307458<space/></arg><arg name="url">http://www.thieme-connect.com/DOI/DOI?10.1055/s-0032-1307458<space/></arg><arg name="accessdate">2014-05-29</arg></template></extension></listitem><listitem>severe electrolyte disorders</listitem><listitem>AIDS</listitem><listitem><link><target>hyperemesis gravidarum</target></link><extension extension_name='ref' name="pmid1393001"><template><target>cite journal</target><arg name="author">Bergin PS, Harvey P<space/></arg><arg name="title">Wernicke's encephalopathy and central pontine myelinolysis associated with hyperemesis gravidarum<space/></arg><arg name="journal">BMJ<space/></arg><arg name="volume">305<space/></arg><arg name="issue">6852<space/></arg><arg name="pages">517–8<space/></arg><arg name="date">August 1992<space/></arg><arg name="pmid">1393001<space/></arg><arg name="pmc">1882865<space/></arg><arg name="doi"><space/>10.1136/bmj.305.6852.517</arg><arg name="url"><space/></arg><arg name="accessdate">2014-05-29</arg></template></extension><extension extension_name='ref' name="pmid23546346"><template><target>cite journal</target><arg name="author">Sutamnartpong P, Muengtaweepongsa S, Kulkantrakorn K<space/></arg><arg name="title">Wernicke's encephalopathy and central pontine myelinolysis in hyperemesis gravidarum<space/></arg><arg name="journal">J Neurosci Rural Pract<space/></arg><arg name="volume">4<space/></arg><arg name="issue">1<space/></arg><arg name="pages">39–41<space/></arg><arg name="date">January 2013<space/></arg><arg name="pmid">23546346<space/></arg><arg name="pmc">3579041<space/></arg><arg name="doi">10.4103/0976-3147.105608<space/></arg><arg name="url">http://www.ruralneuropractice.com/article.asp?issn</arg><arg name="accessdate">2014-05-29</arg></template></extension></listitem><listitem>hyponatremia due to Peritoneal Dialysis</listitem><listitem>Wernicke encephalopathy<extension extension_name='ref' name="pmid22728498"><template><target>cite journal</target><arg name="author">Kishimoto Y, Ikeda K, Murata K, Kawabe K, Hirayama T, Iwasaki Y<space/></arg><arg name="title">Rapid development of central pontine myelinolysis after recovery from Wernicke encephalopathy: a non-alcoholic case without hyponatremia<space/></arg><arg name="journal">Intern. Med.<space/></arg><arg name="volume">51<space/></arg><arg name="issue">12<space/></arg><arg name="pages">1599–603<space/></arg><arg name="year">2012<space/></arg><arg name="pmid">22728498<space/></arg><arg name="doi"><space/>10.2169/internalmedicine.51.7498</arg><arg name="url">http://joi.jlc.jst.go.jp/DN/JST.JSTAGE/internalmedicine/51.7498?from</arg><arg name="accessdate">2014-05-29</arg></template></extension></listitem></list><heading level='2'>Diagnosis</heading><paragraph>It can be difficult to identify using conventional imaging techniques. It presents more prominently on MRI than on CT, often taking several weeks after acute onset of symptoms before it becomes identifiable.Imaging by<space/><link><target>Magnetic resonance imaging</target><part>MRI</part></link><space/>demonstrates an area of high signal return on T2 weighted images.</paragraph><heading level='2'>Symptoms</heading><paragraph><link><target>File:Extrapontine myelinolysis T2 01.jpg</target><part>thumb</part><part>right</part><part>200px</part><part>T2 weighted magnetic resonance scan image showing bilaterally symmetrical hyperintensities in Caudate nucleus (small, thin arrow), Putamen (long arrow), with sparing of Globus Pallidus (broad arrow), suggestive of Extrapontine myelinolysis.</part></link></paragraph><paragraph>Clinical presentation of CPM is heterogeneous and depend on the regions of the brain involved. Observable immediate precursors may include seizures, disturbed consciousness, gait changes, and decrease or cessation of respiratory function.<extension extension_name='ref' name="pmid16218318"><template><target>cite journal</target><arg name="author">Musana AK, Yale SH<space/></arg><arg name="title">Central pontine myelinolysis: case series and review<space/></arg><arg name="journal">WMJ<space/></arg><arg name="volume">104<space/></arg><arg name="issue">6<space/></arg><arg name="pages">56–60<space/></arg><arg name="date">August 2005<space/></arg><arg name="pmid">16218318<space/></arg><arg name="doi"><space/></arg><arg name="url"><space/></arg><arg name="accessdate">2014-05-29</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="pmid"><space/>20148334<space/></arg><arg name="doi">10.1007/s00415-010-5486-7<space/></arg><arg name="volume">257<space/></arg><arg name="issue">7<space/></arg><arg name="title">Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis<space/></arg><arg name="date">July 2010<space/></arg><arg name="author">Odier C, Nguyen DK, Panisset M<space/></arg><arg name="journal">J. Neurol.<space/></arg><arg name="pages">1176–80</arg></template></extension></paragraph><paragraph>Frequently observed symptoms in this disorder are acute para- or<space/><link><target>quadraparesis</target></link>,<space/><link><target>dysphagia</target></link>,<space/><link><target>dysarthria</target></link>,<space/><link><target>diplopia</target></link>,<space/><link><target>coma</target><part>loss of consciousness</part></link>, and other neurological symptoms associated with brainstem damage. The patient may experience<space/><link><target>locked-in syndrome</target></link><space/>where cognitive function is intact, but all muscles are paralyzed with the exception of eye blinking. These result from a rapid myelinolysis of the<space/><link><target>corticobulbar</target></link><space/>and<space/><link><target>corticospinal</target></link><space/>tracts in the brainstem.<extension extension_name='ref' name="pmid8231786"><template><target>cite journal</target><arg name="author">Karp BI, Laureno R<space/></arg><arg name="title">Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia<space/></arg><arg name="journal">Medicine (Baltimore)<space/></arg><arg name="volume">72<space/></arg><arg name="issue">6<space/></arg><arg name="pages">359–73<space/></arg><arg name="date">November 1993<space/></arg><arg name="pmid">8231786<space/></arg><arg name="doi"><space/>10.1097/00005792-199311000-00001</arg><arg name="url"><space/></arg><arg name="accessdate">2014-05-29</arg></template></extension></paragraph><heading level='2'>Prevention and treatment</heading><paragraph>To prevent CPM from its most common cause, overly rapid reversal of hyponatremia, the hyponatremia should be corrected at a rate not exceeding 10&amp;nbsp;mmol/L/24&amp;nbsp;h or 0.5&amp;nbsp;mEq/L/h; or 18 m/Eq/L/48hrs; thus avoiding hypernatremia.<extension extension_name='ref' name="babar"></extension><space/>Details concerning the etiology and correction of electrolyte disorders are discussed extensively in general medicine texts.Alcoholic patients should receive vitamin supplementation and a formal evaluation of their nutritional status.<extension extension_name='ref'><template><target>cite journal</target><arg name="pmid"><space/>7466381<space/></arg><arg name="volume">211<space/></arg><arg name="issue">4486<space/></arg><arg name="title">Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis<space/></arg><arg name="date">March 1981<space/></arg><arg name="author">Kleinschmidt-DeMasters BK, Norenberg MD<space/></arg><arg name="journal">Science<space/></arg><arg name="pages">1068–70<space/></arg><arg name="doi">10.1126/science.7466381</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="pmid"><space/>7348981<space/></arg><arg name="volume">105<space/></arg><arg name="title">Experimental pontine and extrapontine myelinolysis<space/></arg><arg name="year">1980<space/></arg><arg name="author">Laureno R<space/></arg><arg name="journal">Trans Am Neurol Assoc<space/></arg><arg name="pages">354–8</arg></template></extension></paragraph><paragraph>Once demyelination of the pons has begun, there is no cure or specific treatment. Care is supportive, with the goal of preventing complications like<space/><link><target>aspiration pneumonia</target></link><space/>or<space/><link><target>deep vein thrombosis</target></link>. Alcoholics are usually given vitamins to correct for other deficiencies.</paragraph><paragraph>Research has led to improved outcomes.<extension extension_name='ref' name="pmid11148672"><template><target>cite journal</target><arg name="author">Brown WD
</arg><arg name="title">Osmotic demyelination disorders: central pontine and extrapontine myelinolysis
</arg><arg name="journal">Curr. Opin. Neurol.
</arg><arg name="volume">13
</arg><arg name="issue">6
</arg><arg name="pages">691–7
</arg><arg name="date">December 2000
</arg><arg name="pmid">11148672
</arg><arg name="doi">10.1097/00019052-200012000-00014
</arg><arg name="url">http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn</arg></template></extension><space/>Animal studies suggest that<space/><link><target>inositol</target></link><space/>reduces the severity of osmotic demyelination syndrome if given before attempting to correct chronic<space/><link><target>hyponatraemia</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Silver SM, Schroeder BM, Sterns RH, Rojiani AM
</arg><arg name="title"><space/>Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats
</arg><arg name="journal"><space/>J Neuropathol Exp Neurol
</arg><arg name="year"><space/>2006
</arg><arg name="volume"><space/>65
</arg><arg name="issue"><space/>1
</arg><arg name="pages"><space/>37–44
</arg><arg name="pmid">16410747
</arg><arg name="doi"><space/>10.1097/01.jnen.0000195938.02292.39</arg></template></extension><space/>Further study is required before using inositol in humans for this purpose.</paragraph><heading level='2'>Prognosis</heading><paragraph>The prognosis is overall poor. However, recent data indicate that the prognosis of critically ill patients may even be better than what is generally considered,<extension extension_name='ref' name="pmid22036854"><template><target>cite journal</target><arg name="author">Louis G, Megarbane B, Lavoué S, Lassalle V, Argaud L, Poussel JF, Georges H, Bollaert PE<space/></arg><arg name="title">Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis*<space/></arg><arg name="journal">Critical Care Medicine<space/></arg><arg name="volume">40<space/></arg><arg name="issue">3<space/></arg><arg name="pages">970–2<space/></arg><arg name="date">March 2012<space/></arg><arg name="pmid">22036854<space/></arg><arg name="doi">10.1097/CCM.0b013e318236f152<space/></arg><arg name="url">http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn</arg><arg name="accessdate">2014-05-30</arg></template></extension><space/>despite severe initial clinical manifestations and a tendency by the intensivists to underestimate a possible favorable evolution.<extension extension_name='ref' name="pmid22343870"><template><target>cite journal</target><arg name="author">Young GB<space/></arg><arg name="title">Central pontine myelinolysis: a lesson in humility*<space/></arg><arg name="journal">Critical Care Medicine<space/></arg><arg name="volume">40<space/></arg><arg name="issue">3<space/></arg><arg name="pages">1026–7<space/></arg><arg name="date">March 2012<space/></arg><arg name="pmid">22343870<space/></arg><arg name="doi">10.1097/CCM.0b013e31823b8e0b<space/></arg><arg name="url">http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn</arg><arg name="accessdate">2014-05-30</arg></template></extension>While some patients die, most survive and of the survivors, approximately one-third recover; one-third are disabled but are able to live independently; one-third are severely disabled.<extension extension_name='ref' name="pmid16210283"><template><target>cite journal</target><arg name="author">Abbott R, Silber E, Felber J, Ekpo E
</arg><arg name="title">Osmotic demyelination syndrome
</arg><arg name="journal">BMJ
</arg><arg name="volume">331
</arg><arg name="issue">7520
</arg><arg name="pages">829–30
</arg><arg name="date">October 2005
</arg><arg name="pmid">16210283
</arg><arg name="pmc">1246086
</arg><arg name="doi">10.1136/bmj.331.7520.829
</arg><arg name="url">
</arg></template></extension><space/>Permanent disabilities range from minor tremors and<space/><link><target>ataxia</target></link><space/>to signs of severe brain damage, such as<space/><link><target>spastic quadriparesis</target></link><space/>and<space/><link><target>locked-in syndrome</target></link>.<extension extension_name='ref'>http://www.emedicine.com/NEURO/topic50.htm</extension><space/>Some improvements may be seen over the course of the first several months after the condition stabilizes.</paragraph><paragraph>The extent of recovery depends on how many axons were damaged.<extension extension_name='ref' name="pmid12566274"></extension></paragraph><heading level='2'>References</heading><paragraph><template><target>reflist</target><arg>2</arg></template></paragraph><heading level='2'>External links</heading><list type='bullet'><listitem><link type='external' href='http://rad.usuhs.mil/medpix/medpix.html?mode=image_finder&amp;amp;srchstr=osmotic+myelinolysis&amp;amp;search=#top'>MedPix</link><space/>Images of Osmotic Myelinolysis</listitem></list><paragraph><template><target>CNS diseases of the nervous system</target></template></paragraph><paragraph><link><target>Category:Demyelinating diseases of CNS</target></link><link><target>Category:Electrolyte disturbances</target></link></paragraph></article>